Literature DB >> 21885794

Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men.

Isseki Maeda1, Tomoshige Hayashi, Kyoko Kogawa Sato, Hideo Koh, Nobuko Harita, Yoshiko Nakamura, Ginji Endo, Hiroshi Kambe, Kanji Fukuda.   

Abstract

BACKGROUND AND OBJECTIVES: Glomerular hyperfiltration and albuminuria accompanied by early-stage diabetic kidney disease predict future renal failure. Cigarette smoking has reported to be associated with elevated GFR in cross-sectional studies and with renal deterioration in longitudinal studies. The degree of glomerular hyperfiltration and proteinuria associated with smoking, which presumably is a phenomenon of early renal damage, has not been investigated in a satisfying manner so far. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study included 10,118 Japanese men aged 40 to 55 years without proteinuria or renal dysfunction at entry. Estimated GFR was calculated using the Modification of Diet in Renal Disease equation for Japanese. Glomerular hyperfiltration was defined as estimated GFR ≥117.0 ml/min per 1.73 m(2), which was the upper 2.5th percentile value of estimated GFR in the total population. Proteinuria was detected using standard dipstick.
RESULTS: During the 6-year observation period, there were 449 incident cases of glomerular hyperfiltration and 1653 cases of proteinuria. Current smokers had a 1.32-time higher risk for the development of glomerular hyperfiltration and a 1.51-time higher risk for proteinuria than nonsmokers after adjustment for baseline age, body mass index, systolic and diastolic BP, antihypertensive medication, diabetes, alcohol consumption, regular leisure-time physical activity, and estimated GFR. Both daily and cumulative cigarette consumption were associated with an increased risk for glomerular hyperfiltration and proteinuria in a dose-response manner.
CONCLUSIONS: In middle-aged Japanese men, smoking was associated with an increased risk of glomerular hyperfiltration and dipstick proteinuria. Of importance, past smokers did not exhibit any increased risk for these conditions.

Entities:  

Mesh:

Year:  2011        PMID: 21885794      PMCID: PMC3359554          DOI: 10.2215/CJN.00700111

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  [Report on evaluation of clinical laboratory examination of GFR and urinary protein].

Authors:  Y Orita; F Gejyo; Y Ito; H Kimura; A Koyama; T Shiigai; H Tanaka; M Haneda; A Hishida; U Horio; M Yanaqawa; K Kumano; S Abe; S Osawa; K Matoba
Journal:  Nihon Jinzo Gakkai Shi       Date:  2001

Review 2.  Sympathetic nervous system and insulin resistance: from obesity to diabetes.

Authors:  M Esler; M Rumantir; G Wiesner; D Kaye; J Hastings; G Lambert
Journal:  Am J Hypertens       Date:  2001-11       Impact factor: 2.689

3.  Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population.

Authors:  A J Bleyer; L R Shemanski; G L Burke; K J Hansen; R G Appel
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

4.  Obesity-related glomerulopathy: an emerging epidemic.

Authors:  N Kambham; G S Markowitz; A M Valeri; J Lin; V D D'Agati
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

5.  Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population.

Authors:  J M Halimi; B Giraudeau; S Vol; E Cacès; H Nivet; Y Lebranchu; J Tichet
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

6.  Smoking is related to albuminuria and abnormal renal function in nondiabetic persons.

Authors:  S J Pinto-Sietsma; J Mulder; W M Janssen; H L Hillege; D de Zeeuw; P E de Jong
Journal:  Ann Intern Med       Date:  2000-10-17       Impact factor: 25.391

7.  Influence of smoking and obesity on the development of proteinuria.

Authors:  Masahiko Tozawa; Kunitoshi Iseki; Chiho Iseki; Saori Oshiro; Yoshiharu Ikemiya; Shuichi Takishita
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

8.  Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking.

Authors:  Glen S Markowitz; Julie Lin; Anthony M Valeri; Cecilia Avila; Samih H Nasr; Vivette D D'Agati
Journal:  Hum Pathol       Date:  2002-08       Impact factor: 3.466

9.  Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study.

Authors:  Esther M Briganti; Pauline Branley; Steven J Chadban; Jonathan E Shaw; John J McNeil; Timothy A Welborn; Robert C Atkins
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  38 in total

1.  GFR estimating equations: getting closer to the truth?

Authors:  Andrew D Rule; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

2.  U-shaped association between body mass index and proteinuria in a large Japanese general population sample.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2013-05-08       Impact factor: 2.801

3.  Renal hyperfiltration as a novel marker of all-cause mortality.

Authors:  Minseon Park; Eunsil Yoon; Youn-Hee Lim; Ho Kim; Jinwook Choi; Hyung-Jin Yoon
Journal:  J Am Soc Nephrol       Date:  2014-10-24       Impact factor: 10.121

4.  GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts.

Authors:  Bjørn O Eriksen; Runolfur Palsson; Natalie Ebert; Toralf Melsom; Markus van der Giet; Vilmundur Gudnason; Olafur S Indridason; Lesley A Inker; Trond G Jenssen; Andrew S Levey; Marit D Solbu; Hocine Tighiouart; Elke Schaeffner
Journal:  J Am Soc Nephrol       Date:  2020-06-04       Impact factor: 10.121

5.  Association between obesity and glomerular hyperfiltration: the confounding effect of smoking and sodium and protein intakes.

Authors:  Adam Ogna; Valentina Forni Ogna; Murielle Bochud; Idris Guessous; Fred Paccaud; Michel Burnier; Gregoire Wuerzner
Journal:  Eur J Nutr       Date:  2015-05-14       Impact factor: 5.614

6.  The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan.

Authors:  Yuka Noborisaka; Masao Ishizaki; Yuichi Yamada; Ryumon Honda; Hitoshi Yokoyama; Masaru Miyao; Masaji Tabata
Journal:  Environ Health Prev Med       Date:  2012-05-24       Impact factor: 3.674

7.  Albuminuria and hypertension: the chicken or the egg?

Authors:  Yasuyuki Nagasawa; Yukiko Hasuike; Masayoshi Nanami; Takahiro Kuragano; Takeshi Nakanishi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

8.  Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Authors:  Nora Franceschini; Yu Deng; Michael F Flessner; John H Eckfeldt; Holly J Kramer; James P Lash; David J Lee; Michal L Melamed; Ashley E Moncrieft; Ana C Ricardo; Sylvia E Rosas; Robert C Kaplan; Leopoldo Raij; Jianwen Cai
Journal:  Nephrol Dial Transplant       Date:  2016-06-02       Impact factor: 5.992

9.  Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.

Authors:  Gert Jan de Borst; Nicolette G C van der Sande; Frank L J Visseren; Yolanda van der Graaf; Hendrik M Nathoe; Tim Leiner; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-09       Impact factor: 8.237

Review 10.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.